Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus low-dose Asacol in pediatric mildly-to-moderately active ulcerative colitis
2007-005702-49Phase 3Completed
- Sponsor
- Procter & Gamble
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in autoimmune colitis, sponsored by Procter & Gamble. Started Jun 2009; status: completed.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2007-005702-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005702-49.